Multilingual database is in early beta - please report any issues you may have noticed.
Źródło danych:
2022.
Strona zaktualizowana:
2025-05-28
W Korei Północnej terapia zastępcza nikotynowa jest dozwolona, a stosowanie, sprzedaż i zakup produktów NRT w aptekach na receptę są legalne. Rząd udziela częściowego wsparcia finansowego, aby pomóc w pokryciu kosztów terapii zastępczej nikotynowej.
Regulacje
Dozwolone
1
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-prk.pdf?sfvrsn=cabd85a8_3&download=true. Accessed: 6 May 2025.
Dostępność
Tak
1
2022
Nie
1
A
2022
Apteka
1
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-prk.pdf?sfvrsn=cabd85a8_3&download=true. Accessed: 6 May 2025.
Komentarze:
- A prescription is required.
Formalne wsparcie
Tak
1
A
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-prk.pdf?sfvrsn=cabd85a8_3&download=true. Accessed: 6 May 2025.
Komentarze:
- NRT cost is partially covered by the government.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.